Aus der Branche

Kraig Biocraft Laboratories Inc., a leader in spider silk technology, announces that its second production rearing center in Southeast Asia is now fully operational.

With two active production facilities, the Company has established parallel operations designed to ensure continuous rearing cycles of its specialized recombinant spider silk silkworms. This dual-site capacity increases resilience and scalability, providing greater consistency in material output as Kraig Labs advances its commercialization strategy.

Teams are now active at both rearing centers, working with the company’s established parental lines for BAM-1 production hybrids, as well as three additional parental lines introduced earlier this summer. These new genetic lines represent a significant expansion of Kraig Labs’ breeding program and are expected to further enhance production efficiencies.

These facilities are designed to create efficient redundancy to avoid bottlenecks the company experienced in the past. This is a major leap forward in terms of creating sustained production.

“Becoming fully operational at our second rearing center is a milestone that strengthens the foundation of our spider silk production platform,” said Kim Thompson, Kraig Labs founder and CEO. “Having parallel operations allows us to maintain continuous cycles of rearing, diversify our breeding program, and accelerate the development of next-generation hybrids. This expanded capacity is essential as we push forward in scaling production and bringing our recombinant spider silk to market.”

The opening of this second rearing facility reflects Kraig Labs’ ongoing commitment to building a robust, reliable, and scalable spider silk production system in Southeast Asia, positioning the company to meet growing demand from diverse markets and industries.